Browse > Article
http://dx.doi.org/10.3904/kjim.2014.29.1.27

Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern  

Park, Sun Hee (Division of Infectious Diseases, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Publication Information
The Korean journal of internal medicine / v.29, no.1, 2014 , pp. 27-30 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159-166.   DOI   ScienceOn
2 Kang CI, Cha MK, Kim SH, et al. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum ${\beta}$-lactamase-producing Escherichia coli over a 6-year period. J Korean Med Sci 2013;28:998-1004.   DOI
3 Park SH, Byun JH, Choi SM, et al. Molecular epidemiology of extended-spectrum ${\beta}$-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 2012;12:149.   DOI   ScienceOn
4 Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 2013;8:e54714.   DOI
5 Lee JA, Kang CI, Joo EJ, et al. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum ${\beta}$-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 2011;17:267-273.   DOI   ScienceOn
6 Lee S, Han SW, Kim KW, Song DY, Kwon KT. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital. Korean J Intern Med 2014;29:49-56.   DOI
7 Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum ${\beta}$-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother 2012;67:2793-2803.   DOI
8 Rodriguez-Bano J, Navarro MD, Retamar P, et al. ${\beta}$-Lactam/${\beta}$-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum ${\beta}$-lactamase- producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis 2012;54:167-174.   DOI
9 Kang CI, Song JH, Chung DR, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010;36:284-287.   DOI   ScienceOn
10 Park SH, Choi SM, Lee DG, et al. Emergence of extended-spectrum ${\beta}$-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist 2011;17:537-544.   DOI   ScienceOn